Bawahab Mohammed A, Abbas Khaled S, Maksoud Walid M Abd El, Abdelgadir Reem S, Altumairi Khaled, Alqahtani Awadh R, Alzahrani Hassan A, Bhat Muneer Jan
Surgery Department, Faculty of Medicine, King Khalid University, P.O. Box 641, Abha 61421, Saudi Arabia.
General Surgery, Abha International Private Hospital, Abha 62521, Saudi Arabia.
Healthcare (Basel). 2023 Feb 17;11(4):600. doi: 10.3390/healthcare11040600.
Intragastric balloon (IGB) is a safe option for obesity management. However, studies determining the factors influencing the procedure's outcomes are scarce. Therefore, our goal was to determine the factors affecting weight reduction after IGB insertion.
This retrospective study included 126 obese patients who underwent IGB treatment using the ORBERA Intragastric Balloon System. Patients' records were retrieved; and demographic data, initial body mass index (BMI), complications, compliance with both diet and exercise programs, and percentage of excess weight reduction were recorded.
The study included 108 female (85.7%) and 18 male (14.3%) patients. The mean age was 31.7 ± 8.1 years. The percentage of excess weight loss (EWL) was 55.8 ± 35.7%. The mean weight loss was 13.01 ± 7.51 kg. A significant association was found between EWL and age, initial weight, initial body mass index, and the number of pregnancies. No major complications were observed. However, the balloon had to be removed early in two patients (1.59%) due to its rupture and in two other patients (1.59%) due to severe gastritis.
IGB therapy is a safe and effective option for obesity management, associated with low rates of complications. The EWL after IGB insertion is significantly higher among older patients, those with a relatively low initial body mass index, those with a longer duration of IGB insertion, and female patients with less parity. Larger prospective studies are needed to support our results.
胃内球囊（IGB）是肥胖管理的一种安全选择。然而，确定影响该手术效果因素的研究较少。因此，我们的目标是确定影响IGB置入后体重减轻的因素。
这项回顾性研究纳入了126例使用ORBERA胃内球囊系统接受IGB治疗的肥胖患者。检索患者记录；记录人口统计学数据、初始体重指数（BMI）、并发症、饮食和运动计划的依从性以及超重减轻百分比。
该研究包括108名女性（85.7%）和18名男性（14.3%）患者。平均年龄为31.7±8.1岁。超重减轻百分比（EWL）为55.8±35.7%。平均体重减轻为13.01±7.51千克。发现EWL与年龄、初始体重、初始体重指数和妊娠次数之间存在显著关联。未观察到重大并发症。然而，两名患者（1.59%）因球囊破裂、另外两名患者（1.59%）因严重胃炎而不得不提前取出球囊。
IGB治疗是肥胖管理的一种安全有效的选择，并发症发生率较低。在老年患者、初始体重指数相对较低的患者、IGB置入时间较长的患者以及生育次数较少的女性患者中，IGB置入后的EWL显著更高。需要更大规模的前瞻性研究来支持我们的结果。
